More than 80% of AllianceRx Walgreens Prime’s specialty patients are eligible to complete clinical assessments online.
The National Association of Specialty Pharmacy’s Strategic Partner of the Year Award recognized ParcelShield for helping specialty pharmacies ensure more effective on-time delivery of critical medication therapies.
Specialty pharma company Akorn will move forward under a new ownership structure in the coming weeks.
Athena Bioscience's Qdolo is an alternative for patients who have trouble swallowing pills.
A new patented process for delivering specialty medicine will assure that AllianceRx Walgreens Prime patients receive their medicine delivered at the correct temperature, the company said.
Walmart will use Capital Rx's Clearinghouse Model to keep drug prices at bay for specialty and mail-order prescriptions.
Valeo's ethacrynate sodium will be launched this summer.
MaxorPlus clients can choose Amber Pharmacy’s service model for members with organ transplant medication needs.
AmerisourceBergen is providing a unified commercialization approach for Qinlock, a treatment for patients with a rare form of cancer.
Akorn said it will continue to operate as usual throughout the duration of the Chapter 11 and sale process, including meeting its contractual obligations and making payments to vendors.
AllianceRx Walgreens Prime will distribute Lundbeck's Vyepti, an intravenous preventive migraine treatment.
A Surescripts survey finds that nearly two-thirds of specialty pharmacists report spending more than 15 minutes on the phone to fill one prescription.
IQVIA reports that global use of medicine has increased at a 3% compound annual growth rate since 2014, slowing from a 4% rate from 2009–2014.
Glenmark and Hikma will commercialize a fixed-dose combination nasal spray for seasonal allergic rhinitis.